Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Nature Medicine

• Publication date

  2013-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nm.3363PMID 24141423PMCID PMC4041199
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Resveratrol protects against hyperglycemia-induced oxidative damage to mitochondria by activating SIRT1 in rat mesangial cells.

  2012cited by this paper
• De novo expression of podocyte proteins in parietal epithelial cells in experimental aging nephropathy.

  2012cited by this paper
• Can we target tubular damage to prevent renal function decline in diabetes?

  2012cited by this paper
• Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1‐dependent adenosine monophosphate–activated kinase pathway

  2011cited by this paper
• SIRT1 Deacetylates the DNA Methyltransferase 1 (DNMT1) Protein and Alters Its Activities

  2011cited by this paper
• Resveratrol Improves Oxidative Stress and Protects Against Diabetic Nephropathy Through Normalization of Mn-SOD Dysfunction in AMPK/SIRT1-Independent Pathway

  2011cited by this paper
• Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.

  2011cited by this paper
• Dietary Restriction Ameliorates Diabetic Nephropathy through Anti-Inflammatory Effects and Regulation of the Autophagy via Restoration of Sirt1 in Diabetic Wistar Fatty (fa/fa) Rats: A Model of Type 2 Diabetes

  2011cited by this paper
• Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance.

  2011cited by this paper
• De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease.

  2010cited by this paper
• Kidney-specific Overexpression of Sirt1 Protects against Acute Kidney Injury by Retaining Peroxisome Function

  2010cited by this paper
• Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model.

  2010cited by this paper
• Sirt1 activation protects the mouse renal medulla from oxidative injury.

  2010cited by this paper
• Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney.

  2010cited by this paper
• Alterations in the mitochondrial regulatory pathways constituted by the nuclear co-factors PGC-1alpha or PGC-1beta and mitofusin 2 in skeletal muscle in type 2 diabetes.

  2010cited by this paper
• Protective Role of SIRT1 in Diabetic Vascular Dysfunction

  2009cited by this paper
• Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.

  2009cited by this paper
• Molecular Analysis of the Interaction of Anthrax Adenylyl Cyclase Toxin, Edema Factor, with 2′(3′)-O-(N-(methyl)anthraniloyl)-Substituted Purine and Pyrimidine Nucleotides

  2009cited by this paper
• Restoration of Podocyte Structure and Improvement of Chronic Renal Disease in Transgenic Mice Overexpressing Renin

  2009cited by this paper
• Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide.

  2009cited by this paper
• A new function for parietal epithelial cells: a second glomerular barrier.

  2009cited by this paper
• Circadian Control of the NAD+ Salvage Pathway by CLOCK-SIRT1

  2009cited by this paper
• Detection and pharmacological modulation of nicotinamide mononucleotide (NMN) in vitro and in vivo.

  2009cited by this paper
• Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.

  2009cited by this paper
• Allelic Depletion of grem1 Attenuates Diabetic Kidney Disease

  2009cited by this paper
• Ambient glucose levels qualify the potency of insulin myogenic actions by regulating SIRT1 and FoxO3a in C2C12 myocytes.

  2008cited by this paper
• Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression.

  2008cited by this paper
• Age‐associated loss of Sirt1‐mediated enhancement of glucose‐stimulated insulin secretion in beta cell‐specific Sirt1‐overexpressing (BESTO) mice

  2008cited by this paper
• Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy

  2008cited by this paper
• Double Strand Breaks Can Initiate Gene Silencing and SIRT1-Dependent Onset of DNA Methylation in an Exogenous Promoter CpG Island

  2008cited by this paper
• Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex

  2007cited by this paper
• Nuclear relocation of the nephrin and CD2AP-binding protein dendrin promotes apoptosis of podocytes

  2007cited by this paper
• DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinoma.

  2007cited by this paper
• Regulated ATP release from astrocytes through lysosome exocytosis

  2007cited by this paper
• Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice.

  2006cited by this paper
• ZO-1 expression and phosphorylation in diabetic nephropathy.

  2006cited by this paper
• Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility

  2006cited by this paper
• Therapeutic approach for diabetic nephropathy using gene delivery of translocase of inner mitochondrial membrane 44 by reducing mitochondrial superoxide production.

  2006cited by this paper
• Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer.

  2005cited by this paper
• Calorie restriction, SIRT1 and metabolism: understanding longevity

  2005cited by this paper
• Physiological and Pathological Changes in Glucose Regulate Brain Akt and Glycogen Synthase Kinase-3*

  2005cited by this paper
• The role of mammalian DNA methyltransferases in the regulation of gene expression.

  2005cited by this paper
• DNA methylation and histone modifications: teaming up to silence genes.

  2005cited by this paper
• Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice.

  2005cited by this paper
• Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1

  2005cited by this paper
• Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.

  2005cited by this paper
• Epigenetic Inactivation of TMS1/ASC in Ovarian Cancer

  2004cited by this paper
• Podocyte‐specific expression of cre recombinase in transgenic mice

  2003cited by this paper
• Laser microdissection and gene expression analysis on formaldehyde-fixed archival tissue.

  2002cited by this paper
• Analysis of segmental renal gene expression by laser capture microdissection.

  2000cited by this paper
• The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?

  1999cited by this paper
• Kidney-targeted liposome-mediated gene transfer in mice

  1997cited by this paper
• Renal tubular proteinuria and microalbuminuria in diabetic patients.

  1989cited by this paper

• Exploring Bilirubin’s Impact on Autophagy and Apoptosis in Diabetic Kidney Disease

  2026cites this paper
• Resveratrol and Renal Biomarkers in Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2026cites this paper
• Pharmacological potential of Chinese botanical drugs in managing chronic kidney disease by targeting mitochondrial quality control.

  2026cites this paper
• Collagen Deposition in Tuberous Sclerosis Complex Is Driven Through KDM6A-Mediated Activation of ERK/SNAI1 Signaling.

  2026cites this paper
• Beyond hyperglycemia: histone modification-mediated epigenetic dysregulation in diabetic retinopathy and nephropathy.

  2026cites this paper
• Deciphering the Role of Sirtuin‐1 Gene Polymorphism in Diabetic Nephropathy: A Systematic Review and Meta‐Analysis

  2026cites this paper
• Imbalance of mitochondria and abnormalities in lipid metabolism in Diabetic Tubulopathy

  2026cites this paper
• ACSF2-PGK1 interaction promotes ferroptosis in renal tubular epithelial cells of diabetic nephropathy by regulating Keap1/Nrf2 signaling

  2025cites this paper
• Epigenetic regulation by ketone bodies in cardiac diseases and repair.

  2025cites this paper
• Elevated Sirtuin 1 Levels in Patients with Chronic Kidney Disease, Including on Peritoneal Dialysis: Associations with Cardiovascular Risk and Peritoneal Fibrosis

  2025cites this paper
• The Role of Cell-Cell Communication in Renal Damage and the Therapeutic Targeting of Diabetic Kidney Disease

  2025cites this paper
• Association between SIRT-1 and SERPINA4 gene polymorphisms and the risk of idiopathic nephrotic syndrome among Egyptian children

  2025cites this paper
• Evaluation of Intestinal Permeability in Children Diagnosed With Bronchiolitis in Pediatric Emergency Department: A Cross‐Sectional Study

  2025cites this paper
• Cellular cross-talk drives mesenchymal transdifferentiation in diabetic kidney disease

  2025cites this paper
• Epigenetic histone modifications in kidney disease and epigenetic memory

  2025cites this paper
• Potential targets of protecting podocyte in glomerular aging and injury

  2025cites this paper
• USP9X suppresses ferroptosis in diabetic kidney disease by deubiquitinating Nrf2 in vitro

  2025cites this paper
• Role of Nuclear Receptors, Lipid Metabolism, and Mitochondrial Function in the Pathogenesis of Diabetic Kidney Disease.

  2025cites this paper
• Renal insulin-like growth factor binding-protein 7 is a critical promoter of progressive diabetic kidney disease

  2025cites this paper
• SIRT3 deficiency aggravates mitochondrial metabolic disorder and podocyte injury in DKD via MPC2 acetylation.

  2025cites this paper
• Inhibiting miR-200a-3p Increases Sirtuin 1 and Mitigates Kidney Injury in a Tubular Cell Model of Diabetes and Hypertension-Related Renal Damage

  2025cites this paper
• Ginsenoside CK potentiates SIRT1 to alleviate lupus nephritis through compensating for XBP1-mediated endoplasmic reticulum stress in plasma cells

  2025cites this paper
• Novel Coumarin Derivative SZC-6 as an Allosteric Activator of SIRT3 Alleviates Diabetic Kidney Disease via the SIRT3-Foxo3a Signaling Axis.

  2025cites this paper
• The Role of the Vascular Niche in Regulating Kidney Tubulo-Interstitial Fibrosis.

  2025cites this paper
• Mitochondrial dysfunction: the hidden catalyst in chronic kidney disease progression

  2025cites this paper
• Voclosporin Overdose-Induced Peroxisomal Structural Changes and AKI Are Prevented by Renal Indole Detoxifier, INMT.

  2025cites this paper
• Dysregulation of Niacin-Derived NAD+ Salvage Pathway Markers (CD38, NAMPT, SIRT1) Across Albuminuria Stages in Type 2 Diabetes

  2025cites this paper
• Niao-Du-Kang granules regulate autophagy of diabetic nephropathy via the miR-214-3p/SIRT1 signaling pathway.

  2025cites this paper
• Huangkui capsule combined with finerenone attenuates diabetic nephropathy by regulating the JAK2/STAT3 signaling pathway based on network pharmacology, molecular docking, and experimental verification

  2025cites this paper
• Mesangial Cells in Diabetic Kidney Disease: From Mechanisms to Therapeutic Implications

  2025cites this paper
• The hidden danger: the epigenetic landscape of fluoride-induced kidney damage and its role in chronic kidney disease

  2025cites this paper
• Claudin-1 impairs blood–brain barrier by downregulating endothelial junctional proteins in traumatic brain injury

  2025cites this paper
• Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitis.

  2025cites this paper
• The effect of Dapagliflozin on diabetic nephropathy through PRMT1-SIRT1-FoxO1 pathway-mediated autophagy.

  2025cites this paper
• CXCL6 Orchestrates Macrophage-Driven Inflammation in Diabetic Kidney Disease and Represents a Druggable Target

  2025cites this paper
• Claudin-1 Inhibitor PDS-0330 Ameliorates Diabetic Kidney Disease by Suppressing Src/Akt/mTOR Signaling Pathway in Podocytes

  2025cites this paper
• Angiopoietins: A potential therapeutic target in the treatment of diabetic nephropathy

  2025cites this paper
• Fructose overconsumption accelerates renal dysfunction with aberrant glomerular endothelial-mesangial cell interactions in db/db mice.

  2024cites this paper
• Sirtuins in kidney diseases: potential mechanism and therapeutic targets

  2024cites this paper
• Sirtuins in kidney health and disease

  2024cites this paper
• Central role of podocytes in mediating cellular crosstalk in glomerular health and disease.

  2024cites this paper
• Review on Kidney-Liver Crosstalk: Pathophysiology of Their Disorders

  2024cites this paper
• Adverse effects of acute tubular injury on the glomerulus: contributing factors and mechanisms

  2024cites this paper
• The renoprotective effect of Tibolone in sepsis-induced acute kidney injury.

  2024cites this paper
• Roles of Sirt1 and its modulators in diabetic microangiopathy: A review.

  2024cites this paper
• Evaluating the State of Glomerular Disease by Analyzing Urinary Sediments: mRNA Levels and Immunofluorescence Staining for Various Markers

  2024influential citation
• Unraveling the nexus of NAD+ metabolism and diabetic kidney disease: insights from murine models and human data

  2024cites this paper
• ESRRA modulation by empagliflozin mitigates diabetic tubular injury via mitochondrial restoration.

  2024cites this paper
• Association of high vibration perception threshold with reduced renal function in patients with type 2 diabetes

  2024cites this paper
• Crosstalk between glomeruli and tubules

  2024influential citation
• Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials

  2024cites this paper
• NAD+ enhancers as therapeutic agents in the cardiorenal axis

  2024cites this paper
• SGLT2 Inhibitors and Finerenone: A friendly Duo in the Treatment of Diabetic Kidney Disease?

  2024cites this paper
• Caloric and time restriction diets improve acute kidney injury in experimental menopausal rats: role of silent information regulator 2 homolog 1 and transforming growth factor beta 1

  2024cites this paper
• Urinary SIRT2 Reflects Kidney Injury in Type 2 Diabetes.

  2024cites this paper
• Exploring the Critical Role of Tight Junction Proteins in Kidney Disease Pathogenesis

  2024influential citation
• Circadian light/dark cycle reversal exacerbates the progression of chronic kidney disease in mice

  2024cites this paper
• Identification of Spatial Specific Lipid Metabolic Signatures in Long-Standing Diabetic Kidney Disease

  2024cites this paper
• The Impact of Epigenetics on the Pathophysiology of Type 2 Diabetes and Associated Nephropathic Complications

  2024cites this paper
• Nmnat1 Deficiency Causes Mitoribosome Excess in Diabetic Nephropathy Mediated by Transcriptional Repressor HIC1

  2024cites this paper
• Nimbidiol protects from renal injury by alleviating redox imbalance in diabetic mice

  2024cites this paper
• Nicotinamide protects against diabetic kidney disease through regulation of Sirt1

  2024cites this paper
• Epigenetic alterations and memory: key players in the development/progression of chronic kidney disease promoted by acute kidney injury and diabetes.

  2024cites this paper
• Therapeutic potential of bark extracts from Macaranga denticulata on renal fibrosis in streptozotocin-induced diabetic rats

  2024cites this paper
• Genome editing and kidney health

  2024cites this paper
• Mechanisms and Implications of Podocyte Autophagy in Chronic Kidney Disease.

  2024cites this paper
• Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma

  2024cites this paper
• VDR restores the expression of PINK1 and BNIP3 in TECs of streptozotocin-induced diabetic mice

  2024cites this paper
• Effect of nattokinase on the pathological conditions in streptozotocin induced diabetic rats

  2024cites this paper
• Skin keratinocyte-derived SIRT1 and BDNF modulate mechanical allodynia in mouse models of diabetic neuropathy.

  2024cites this paper
• Podocyte-related biomarkers' role in evaluating renal toxic effects of silver nanoparticles with the possible ameliorative role of resveratrol in adult male albino rats

  2024cites this paper
• Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death.

  2024cites this paper
• Effect of Borreria hispida Extract on SIRT1, HIF-1α, ET-1 and VEGFR-2 Gene Expression in NRK-52E Cells Subjected to Glucotoxicity

  2024cites this paper
• Scopoletin alleviates high glucose-induced toxicity in human renal proximal tubular cells via inhibition of oxidative damage, epithelial-mesenchymal transition, and fibrogenesis

  2024cites this paper
• Advance in Iron Metabolism, Oxidative Stress and Cellular Dysfunction in Experimental and Human Kidney Diseases

  2024cites this paper
• Ability of NAD and Sirt1 to epigenetically suppress albuminuria

  2024influential citation
• Epidermal SIRT1 and BDNF modulate mechanical allodynia in mouse models of diabetic neuropathy

  2023cites this paper
• Epidermal SIRT1 and BDNF modulate mechanical allodynia in mouse models of diabetic neuropathy

  2023cites this paper
• Evaluation of glomerular sirtuin-1 and claudin-1 in the pathophysiology of nondiabetic focal segmental glomerulosclerosis

  2023cites this paper
• Insights into the Therapeutic Potential of Phytoconstituents as an Epigenetic Modulators in Diabetic Nephropathy

  2023cites this paper
• Functioning and mechanisms of PTMs in renal diseases

  2023cites this paper
• VDR Activation Attenuates Renal Tubular Epithelial Cell Ferroptosis by Regulating Nrf2/HO‐1 Signaling Pathway in Diabetic Nephropathy

  2023cites this paper
• 肾小管上皮细胞应激性衰老在糖尿病肾病中的研究进展

  2023cites this paper
• Cellular crosstalk of mesangial cells and tubular epithelial cells in diabetic kidney disease

  2023influential citation
• New insights into the mechanisms of diabetic kidney disease: Role of circadian rhythm and Bmal1.

  2023cites this paper
• Therapeutic application of traditional Chinese medicine in kidney disease: Sirtuins as potential targets.

  2023cites this paper
• Regulation of autophagy by natural polyphenols in the treatment of diabetic kidney disease: therapeutic potential and mechanism

  2023cites this paper
• Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms

  2023cites this paper
• Targeted deletion of von-Hippel-Lindau in the proximal tubule conditions the kidney against early diabetic kidney disease

  2023cites this paper
• Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns.

  2023cites this paper
• Differential correlation between time in range and eGFR or albuminuria in type 2 diabetes

  2023cites this paper
• Carnosine alleviates kidney tubular epithelial injury by targeting NRF2 mediated ferroptosis in diabetic nephropathy

  2023cites this paper
• Aging and Diabetic Kidney Disease: Emerging Pathogenetic Mechanisms and Clinical Implications.

  2023cites this paper
• Epigenetics of the Pathogenesis and Complications of Type 2 Diabetes Mellitus

  2023cites this paper
• Deacetylation via SIRT2 prevents keratin-mutation-associated injury and keratin aggregation

  2023cites this paper
• The role of claudins in homeostasis

  2023cites this paper
• The complexity of nicotinamide adenine dinucleotide (NAD), hypoxic, and aryl hydrocarbon receptor cell signaling in chronic kidney disease

  2023cites this paper
• The Pathogenesis of Diabetes

  2023cites this paper
• GYY4137, a H2S donor, ameliorates kidney injuries in diabetic mice by modifying renal ROS-associated enzymes.

  2023cites this paper
• The beneficial effects of astragaloside IV on ameliorating diabetic kidney disease.

  2023cites this paper